Drugs

Therapeutic Drug Monitoring in the Treatment of Tuberculosis
pp. 2169-2183(15)
Author: Peloquin C.A.

HMG-CoA Reductase Inhibitors as Immunomodulators: Potential Use in Transplant Rejection
pp. 2185-2191(7)
Authors: Raggatt L.J.; Partridge N.C.

Pharmacological Strategies to Decrease Transfusion Requirements in Patients Undergoing Surgery
pp. 2193-2211(19)
Authors: Porte R.J.; Leebeek F.W.G.

Prevention of Perinatal HIV Transmission: Current Status and Future Developments in Anti-Retroviral Therapy
pp. 2213-2220(8)
Author: Kourtis A.P.

Biapenem
pp. 2221-2234(14)
Authors: Perry C.M.; Ibbotson T.

Biapenem: A Viewpoint by Yukimichi Kawada
pp. 2235-2235(1)
Author: Kawada Y.

Biapenem: A Viewpoint by Carl Erik Nord
pp. 2235-2235(1)
Author: Nord C.E.

Gefitinib
pp. 2237-2248(12)
Authors: Culy C.R.; Faulds D.

Gefitinib: A Viewpoint by Giuseppe Giaccone
pp. 2249-2250(2)
Author: Giaccone G.

Gefitinib: A Viewpoint by Lesley Seymour
pp. 2249-2250(2)
Author: Seymour L.

Geftinib: A Viewpoint by Fortunato Ciardiello
pp. 2249-2250(2)
Author: Ciardiello F.

Extended-Release Methylphenidate (Ritalin LA)
pp. 2251-2259(9)
Authors: Lyseng-Williamson K.A.; Keating G.M.

Extended-Release Methylphenidate (Ritalin LA): A Viewpoint by Daniel J. Safer
pp. 2260-2261(2)
Author: Safer D.J.

Extended-Release Methylphenidate (Ritalin LA): A Viewpoint by Sharon B. Wigal
pp. 2260-2261(2)
Author: Wigal S.B.

Budesonide (Entocort EC Capsules): A Review of its Therapeutic Use in the Management of Active Crohn's Disease in Adults
pp. 2263-2282(20)
Authors: McKeage K.; Goa K.L.

Danaparoid: A Review of its Use in Thromboembolic and Coagulation Disorders
pp. 2283-2314(32)
Authors: Ibbotson T.; Perry C.M.